Estrogen and progesterone receptor status of mammary carcinomas and correlation with clinical outcome in dogs

Abstract

Summary Estrogen and progesterone receptors (er, pr) were measured in cytosol fractions from 18 primary canine mammary carcinomas by use of biochemical assays. One or both receptors were detected (> 10 fmol/mg of cytosol protein) in 11 tumors: 5 er and pr; 2 er only; 4 pr only. Mean cytoplasmic receptor concentrations (fmol/mg of cytosol protein) were 22.8 ± 2.9 (sem) for er and 51.0 ± 10.3 for pr in tumors containing er and pr, 28.8 ± 12.1 for er in tumors containing only er and 13.2 ± 1.5 for pr in tumors containing only pr. Estrogen or progesterone receptors or both were identified in 6 of 9 tubular adenocarcinomas, 4 of 5 papillary adenocarcinomas, and 1 of 1 squamous cell carcinoma. These receptors were not identified in solid carcinomas (n = 2) or a single spindle cell carcinoma. Although the number of cases was limited, survival times of dogs tended to be longest in those with tumors containing er alone or in combination with pr, intermediate in those with tumors containing only pr, and shortest in those with tumors without er or pr. A correlation was not apparent between receptor status and age, presence of ovaries, tumor size, or histologic classification of the tumor. In the analysis of this series, the extent of surgery (mastectomy of the involved gland vs unilateral or bilateral mastectomy) did not appear to influence the outcome of the disease, and metastasis to regional lymph nodes did not appear to be a reliable prognostic indicator.